<DOC>
	<DOC>NCT01683409</DOC>
	<brief_summary>This is a dose ranging study to evaluate the safety and efficacy of baricitinib in the treatment of participants with mild to moderate diabetic kidney disease.</brief_summary>
	<brief_title>A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<criteria>Participants with Type 2 diabetes treated with at least one antihyperglycemic medicine for 12 months Have diabetic kidney disease and receiving one of two specific medicines used to treat high blood pressure or diabetic kidney disease for at least 3 months Estimated Glomerular Filtration Rate (eGFR) of 25 to 70 milliliter per minute per 1.73 square meter (mL/min/1.73 m^2) (as determined by the Chronic Kidney Disease Epidemiology Collaboration equation) and a urinary albumin/creatinine ratio (UACR) &gt;300 milligram per gram (mg/g) and &lt;5000 mg/g Too high blood pressure when you enter the study Some specific medicines used to treat high blood pressure or diabetic kidney disease Frequent high blood glucose levels Renal transplant or past history of dialysis Nonsteroidal antiinflammatory drugs (NSAIDs) Had a special Xray in the past 30 days which involved also receiving an injection of dye into the vein Major surgery within 8 weeks of study entry or will require major surgery during the study Some types of vaccination Shingles or currently have symptoms of a cold sore Serious viral, bacterial, fungal, or parasitic infection, or a urinary infection, Tuberculosis (TB) Human immunodeficiency virus (HIV) infection the virus that causes Acquired immunodeficiency syndrome (AIDS) Have or had some blood disorders, enlarged lymph glands or spleen, or some cancers. Serious circulatory, breathing, liver, stomach or bowel problems, neurological or psychiatric disorders Heart attack or heart failure, or a stroke Other serious disorders or illnesses Electrocardiogram (ECG) heart trace abnormalities Alcohol or illegal drug abuse Donated more than 500 mL of blood in the last 30 days (no blood donations allowed during the study) Pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>